PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-185.65%
Both yoy net incomes decline, with MRVL at -69.83%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
10.42%
D&A growth well above MRVL's 4.18%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-133.33%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
142.46%
Well above MRVL's 28.08% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
79.63%
Inventory growth well above MRVL's 118.18%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
123.45%
Some yoy usage while MRVL is negative at -145.19%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
138.10%
Growth of 138.10% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
392.44%
Some CFO growth while MRVL is negative at -24.29%. John Neff would note a short-term liquidity lead over the competitor.
62.00%
CapEx growth well above MRVL's 26.72%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-80.35%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
16.62%
Liquidation growth of 16.62% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
60.91%
Investing outflow well above MRVL's 64.45%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
7.14%
Lower share issuance yoy vs. MRVL's 6725.44%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-2057.14%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.